Monocyte to HDL ratio: a novel marker of resistant hypertension in CKD patients
ConclusionsMHR may be a reliable biomarker due to the connection between HDL and monocytes. Our study suggests that MHR is linked with the use of multiple anti-hypertensive therapy and resistant hypertension in CKD patients, and can be a useful ratio to implement appropriate treatment strategies.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
More News: Antidoxidants | Cardiology | Cardiovascular | Cholesterol | Chronic Kidney Disease | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Hypertension | Study | Urology & Nephrology